- The Latte
- Posts
- The Tech Chill After the Boom
The Tech Chill After the Boom
Nvidia tumbles, data goes dark, and markets relearn that momentum needs proof.


Is the AI Bubble About to Burst? (95.2% Accurate Forecast)
NVIDIA officially reports earnings November 19, but you can get a sneak peek right now.
Not just for NVIDIA, but for dozens of public companies.
On Polymarket, the world's largest prediction market (with verified 95.2% accuracy), you can see what top forecasters believe will happen.
Our new Earnings Markets let you:
See real-time odds of NVIDIA beating estimates
Predict what executives will say on earnings calls
Profit directly from being right, regardless of stock price movement
Trade simple Yes/No outcomes instead of complex options
Will Jensen stun Wall Street again?
Or is the AI trade finally cooling off?
Top forecasters are already positioning.
👋 ICYMI
Markets stumbled this week as Big Tech shares dragged, despite earlier optimism. The S&P 500 fell ~1.6%, and the Nasdaq Composite tumbled ~3%, as tech heavyweights such as Nvidia Corporation $NVDA ( ▲ 0.04% ) (-7%), and Microsoft Corporation $MSFT ( ▼ 0.06% ) (-4%) weighed on the market. The downturn came amid renewed worries about inflated tech valuations and a lack of fresh economic data due to the ongoing U.S. government shutdown.
🔁 Market Movers
📉 Tech Stocks Slip as Easing Hopes Fade
The pull-back in major technology names undermined the broader market this week, as investor hopes for Fed easing dimmed. Nvidia, Microsoft and Amazon were key drags.🗓️ Earnings Calendar Bulges Ahead
With earnings reports from dozens of companies this week (including tech, healthcare, fintech), investors remain alert for surprises as macro data remains scarce.🌍 Economic Uncertainty Grows with Missing Data & Shutdown
The continued government shutdown is delaying key economic releases, which has raised concern about the clarity of the Fed’s policy path and the underlying economy.
👀 Signals I’m Watching
📊 Market Breadth Weakens
Technical signals show falling participation beneath the surface, with indexes losing breadth even as some large caps hold up.💼 Tech Valuation Risk Returns
The scale of recent tech cap-ex and AI investment is impressive—but investors are asking when the spending will turn into earnings growth.⏳ Data Vacuum Creates Blind Spots
With economic reports delayed and hiring freezes increasing, there’s less visibility into the real economy—raising the chance of a surprise.🧮 Crowded Trades Face Reversal Risk
Tech and AI trades remain crowded. In a market where optimism is high but confirmation is low, reversals can occur fast.
One of my newest portfolio additions — which I recently revealed to members — is Chime Financial $CHYM ( ▲ 12.44% ). In a recent newsletter, I broke down why this fintech standout is mispriced and misunderstood by the market.
Well… the market is starting to catch on. 🚀
$CHYM ( ▲ 12.44% ) rocketed nearly 20% last week, despite a challenging backdrop, after delivering a powerhouse earnings report with strong top- and bottom-line results.
If you want full access to all my stock ideas, deep-dive research, and our exclusive Discord community where I share real-time insights, you can become a premium member here! 💯✨
⚠️ Red Flag to Note
Markets are rallying on hope, not new proof. With data releases delayed and major tech valuations stretched, the risk of a sharp pull-back is elevated. A smaller than expected earnings beat—or negative corporate outlook—could trigger outsized moves given positioning.
🔍 Insider Transactions I’m Watching
Ticker | Insider | Action | Value | Why It Matters |
|---|---|---|---|---|
Director | Sell | ~$185M | Very large sale by a board member in a major med-tech name; scale raises red-flag on sentiment in this sector. | |
CEO & President | Sell | ~$32.1M | A meaningful trim by the CEO of a growth diagnostics company; worth noting given sector momentum. | |
$XZO | Paresh Patel — CEO & Director | Buy | ~$1.05M | A meaningful insider purchase in a newly-filing AI analytics player — signals CEO confidence at IPO stage. |
→✨NEW ✨ My framework for reading insider moves — when buy signals outweigh noise (and when they don’t)
🚀IPO Watch
🗓️Recent IPOs
🧠 Exzeo Group ($XZO) — The insurtech firm raised $168 million, priced at $21/share this week ($20–22 range) with valuation of ~$1.9 billion.
🧬 BillionToOne ($BLLN) — Precision-genomics company raised ~$273 million in its IPO this week, with shares opening well above the offer; valuation hit ~$5.8 billion.
💊 Evommune ($EVMN) — The clinical-stage biotech developing therapies for inflammatory and autoimmune diseases priced its IPO this week at $16/share for ~9.4 million shares, raising ~$150 million.
📬 Closing Note
The rally remains intact—but its foundation is under-tested. With tech pulling back, lack of fresh macro data, and investor positioning elevated, now isn’t the time for complacency. Focus on companies that deliver—not just promise—and keep your reserves ready for volatility.
Until next Sunday —
George

